{"id":"https://openalex.org/W2103196676","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1509","title":"Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies","display_name":"Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies","publication_year":2008,"publication_date":"2008-01-15","ids":{"openalex":"https://openalex.org/W2103196676","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1509","mag":"2103196676","pmid":"https://pubmed.ncbi.nlm.nih.gov/18223225"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-07-1509","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1509","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1509","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis M. Weiner","raw_affiliation_strings":["1Georgetown University Medical Center, Washington, District of Columbia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Georgetown University Medical Center, Washington, District of Columbia;","institution_ids":["https://openalex.org/I2799903593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108509552","display_name":"Arie S. Belldegrun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arie S. Belldegrun","raw_affiliation_strings":["2University of California at Los Angeles School of Medicine, Los Angeles, California;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of California at Los Angeles School of Medicine, Los Angeles, California;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037771704","display_name":"Jeffrey Crawford","orcid":"https://orcid.org/0000-0002-1274-1354","observed_orcids":["https://orcid.org/0000-0002-1274-1354"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Crawford","raw_affiliation_strings":["3Duke University Medical Center, Durham, North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Duke University Medical Center, Durham, North Carolina;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony W. Tolcher","raw_affiliation_strings":["4Cancer Therapy and Research Center, San Antonio, Texas;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cancer Therapy and Research Center, San Antonio, Texas;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085343063","display_name":"Pamela Lockbaum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela Lockbaum","raw_affiliation_strings":["5Abgenix, Inc., Fremont, California; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Abgenix, Inc., Fremont, California; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087951804","display_name":"Rosalin Arends","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosalin H. Arends","raw_affiliation_strings":["5Abgenix, Inc., Fremont, California; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Abgenix, Inc., Fremont, California; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047941286","display_name":"Lynn Navale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Navale","raw_affiliation_strings":["6Amgen, Inc., Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Amgen, Inc., Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101756946","display_name":"Rafael G. Amado","orcid":"https://orcid.org/0000-0003-4241-2196","observed_orcids":["https://orcid.org/0000-0003-4241-2196"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafael G. Amado","raw_affiliation_strings":["6Amgen, Inc., Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Amgen, Inc., Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011713808","display_name":"Gisela M. Schwab","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gisela Schwab","raw_affiliation_strings":["5Abgenix, Inc., Fremont, California; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Abgenix, Inc., Fremont, California; and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Figlin","raw_affiliation_strings":["2University of California at Los Angeles School of Medicine, Los Angeles, California;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of California at Los Angeles School of Medicine, Los Angeles, California;","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.7757,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.9752809,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"14","issue":"2","first_page":"502","last_page":"508"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.18330000340938568,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":1.0},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9300000071525574},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7179999947547913},{"id":"https://openalex.org/keywords/dose-and-schedule","display_name":"dose and schedule","score":0.6069999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.871999979019165},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.6499999761581421},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.6740000247955322},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.5609999895095825},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7710000276565552},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7910000085830688},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.5809999704360962},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9749628901481628},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8277255296707153},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6073450446128845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5786390900611877},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5238716006278992},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5181349515914917},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5084565877914429},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4949738383293152},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4865957498550415},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4533195197582245},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4426734447479248},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4150565266609192},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.40870535373687744},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3816167116165161},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37101221084594727},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2604921758174896},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-07-1509","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1509","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1509","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:18223225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18223225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1633862704","display_name":null,"funder_award_id":"R01 CA050633","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W93204923","https://openalex.org/W224697977","https://openalex.org/W1546210634","https://openalex.org/W1550092936","https://openalex.org/W1964321121","https://openalex.org/W1972004339","https://openalex.org/W2002959795","https://openalex.org/W2032359283","https://openalex.org/W2037521712","https://openalex.org/W2046225622","https://openalex.org/W2049623985","https://openalex.org/W2064047613","https://openalex.org/W2074987421","https://openalex.org/W2097121246","https://openalex.org/W2121306031","https://openalex.org/W2122885616","https://openalex.org/W2139819066","https://openalex.org/W2139937771","https://openalex.org/W2142564546","https://openalex.org/W2158179945","https://openalex.org/W2164837623","https://openalex.org/W2167805334","https://openalex.org/W2168377135","https://openalex.org/W2231490115","https://openalex.org/W2245105816","https://openalex.org/W2337361698","https://openalex.org/W2400430244","https://openalex.org/W2599727572","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2171311886","https://openalex.org/W2066082532","https://openalex.org/W4318274231","https://openalex.org/W3000288349","https://openalex.org/W2128507784","https://openalex.org/W2144453024","https://openalex.org/W2404865584","https://openalex.org/W1652638408","https://openalex.org/W1972070251","https://openalex.org/W2350493697"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"phase":[2],"1":[3],"study":[4],"evaluated":[5],"the":[6,21,169,223,242],"safety,":[7],"pharmacokinetics,":[8],"and":[9,55,66,94,118,133,178,199,219,228,235],"activity":[10],"of":[11,49,124,138,187,201],"panitumumab,":[12],"a":[13,195],"fully":[14],"human,":[15],"IgG2":[16],"monoclonal":[17],"antibody":[18],"that":[19],"targets":[20],"epidermal":[22,31],"growth":[23,32],"factor":[24,33],"receptor":[25],"in":[26,168,241,259],"patients":[27,83,97,189,203,260],"with":[28,191,205,216,261],"previously":[29],"treated":[30],"receptor-expressing":[34],"advanced":[35,262],"solid":[36],"tumors.":[37],"EXPERIMENTAL":[38],"DESIGN:":[39],"Sequential":[40],"cohorts":[41,244],"were":[42,69,98,102,154,161,166],"enrolled":[43],"to":[44],"receive":[45],"four":[46],"i.v.":[47],"infusions":[48],"panitumumab":[50,158,164],"monotherapy":[51],"at":[52,71,78],"various":[53],"doses":[54],"schedules.":[56,233],"Safety":[57],"was":[58,76,89,131,141,148,213],"continuously":[59],"monitored.":[60],"Serum":[61,163],"samples":[62],"for":[63,222],"pharmacokinetic,":[64],"immunogenicity,":[65],"chemistry":[67],"assessments":[68],"drawn":[70],"preset":[72],"intervals.":[73],"Tumor":[74,100],"response":[75],"assessed":[77],"week":[79],"8.":[80],"RESULTS:":[81],"Ninety-six":[82],"received":[84],"panitumumab.":[85],"Median":[86],"(range)":[87],"age":[88],"61":[90],"years":[91],"(32-79":[92],"years),":[93],"72":[95],"(75%)":[96],"male.":[99],"types":[101],"41%":[103],"colorectal":[104,192,206,263],"cancer,":[105],"22%":[106],"prostate,":[107],"16%":[108],"renal,":[109],"15%":[110],"non-small":[111],"cell":[112],"lung,":[113],"3%":[114,116],"pancreatic,":[115],"esophageal/gastroesophageal,":[117],"1%":[119],"anal.":[120],"The":[121,136],"overall":[122],"incidence":[123,137],"grade":[125],"3":[126,182,230],"or":[127,247],"4":[128],"adverse":[129],"events":[130],"32%":[132],"7%,":[134],"respectively.":[135],"skin-related":[139],"toxicities":[140],"dose":[142,147,184,243],"dependent.":[143],"No":[144,150,156],"maximum":[145],"tolerated":[146,215],"reached.":[149],"human":[151],"anti-panitumumab":[152],"antibodies":[153],"detected.":[155],"investigator-determined":[157],"infusion-related":[159],"reactions":[160],"reported.":[162],"concentrations":[165],"similar":[167],"2.5":[170],"mg/kg":[171,174,180,249],"weekly,":[172,224],"6.0":[173],"every":[175,181,225,229],"2":[176,226],"weeks,":[177,227],"9.0":[179],"weeks":[183,231],"cohorts.":[185],"Five":[186],"39":[188,202],"(13%)":[190],"cancer":[193,207],"had":[194,208],"confirmed":[196],"partial":[197],"response,":[198],"9":[200],"(23%)":[204],"stable":[209],"disease.":[210],"CONCLUSIONS:":[211],"Panitumumab":[212,252],"well":[214],"comparable":[217],"exposure":[218],"safety":[220],"profiles":[221],"administration":[232],"Rash":[234],"dry":[236],"skin":[237],"occurred":[238],"more":[239],"frequently":[240],"receiving":[245],">":[246],"=2.5":[248],"weekly":[250],"dose.":[251],"has":[253],"single-agent":[254],"antitumor":[255],"activity,":[256],"most":[257],"notably":[258],"cancer.":[264]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":12}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}